Efficacy of Serum Anti-Mullerian Hormone (AMH) Levels for Prediction of Polycystic Ovary Syndrome (PCOS) and Its Association With Clinical, Biochemical, and Hormonal Parameters

September 2022 in “ Indian Journal of Clinical Biochemistry ”

Sajad Sumji, Abid Bhat, Aafia Rashid, Rohina Bashir, Imtiyaz Ahmad Wani, Vishnu Vasudevan, Tajali Sehar, Mohd Ashraf Ganie

We don't know much about this study yet.

We're maintaining the world's largest resposity of hair loss research. You can help out the community by sending a PDF of this study here . Not sure how to get a study's PDF? You can email the authors of the study.

View this study on pmc.ncbi.nlm.nih.gov →

Discuss this study in the Community →

Research cited in this study

3 / 3 results

research Antimüllerian Hormone to Determine Polycystic Ovarian Morphology: The APHRODITE Study

21 citations , September 2021 in “Fertility and Sterility”

A blood test level of 3.2 ng/mL of Antimüllerian hormone is good for identifying polycystic ovarian morphology in European women aged 25–45.

research Age-Specific Cut-Off Levels of Anti-Müllerian Hormone as Diagnostic Markers for Polycystic Ovary Syndrome

8 citations , May 2021 in “Reproductive Biology and Endocrinology”

Different levels of anti-Müllerian hormone can help diagnose polycystic ovary syndrome in women of different ages.

research Accuracy of Anti-Müllerian Hormone and Total Follicle Count to Diagnose Polycystic Ovary Syndrome in Reproductive Women

13 citations , August 2018 in “Taiwanese Journal of Obstetrics & Gynecology”

AMH is a good marker for diagnosing PCOS, but global standards are needed.